碘与代谢综合征相关性的研究进展

doi:10.16352/j.issn.1001-6325.2022.06.009

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (6): 979-982.doi: 10.16352/j.issn.1001-6325.2022.06.009

碘与代谢综合征相关性的研究进展

许晓双¹, 闵行^1,2, 叶月^1,2, 郭梦然^1,2, 甄东户^2*

1.兰州大学第一临床医学院, 甘肃兰州 730030;
2.兰州大学第一医院内分泌科, 甘肃兰州 730000

收稿日期:2021-01-27 修回日期:2021-06-03 出版日期:2022-06-05 发布日期:2022-06-02
通讯作者: * zhdh8279@163.com
基金资助:
上海市医药卫生发展基金会糖尿病临床研究项目(1期10研究);标准化代谢性疾病管理中心(MMC)专项研究基金(2018-mmczxjj-3)

Research progress on the correlation between iodine and metabolic syndrome

XU Xiao-shuang¹, MIN Hang^1,2, YE Yue^1,2, GUO Meng-ran^1,2, ZHEN Dong-hu^2*

1. the First Clinical Medical College, Lanzhou University, Lanzhou 730030;
2. Department of Endocrinology,the First Hospital of Lanzhou University,Lanzhou 730000,China

Received:2021-01-27 Revised:2021-06-03 Online:2022-06-05 Published:2022-06-02
Contact: * zhdh8279@163.com

摘要/Abstract

摘要： 代谢综合征(Mets)是一系列心血管疾病的高危因素。碘营养状态的改变可直接介导胰岛素抵抗的发生,影响糖脂代谢及血压水平的调节,亦可通过调节甲状腺功能间接参与Mets的发病过程。探索碘在Mets发生发展中的作用,可为预防和治疗Mets提供新的思路。

关键词: 碘, 代谢综合征, 甲状腺激素, 胰岛素抵抗

Abstract: Metabolic syndromes (Mets) is a high-risk factor for a series of cardiovascular diseases. Changes in iodine nutritional status can directly mediate the occurrence of insulin resistance, affect glucose and lipid metabolism and the regulation of blood pressure and also,may contribute to the pathogenesis of Mets by regulating thyroid function. Exploring the role of iodine in the occurrence and development of Mets can provide new ideas for the prevention and treatment of Mets.

Key words: iodine, metabolic syndrome, thyroid hormone, insulin resistance

中图分类号:

R589.9

许晓双, 闵行, 叶月, 郭梦然, 甄东户. 碘与代谢综合征相关性的研究进展[J]. 基础医学与临床, 2022, 42(6): 979-982.

XU Xiao-shuang, MIN Hang, YE Yue, GUO Meng-ran, ZHEN Dong-hu. Research progress on the correlation between iodine and metabolic syndrome[J]. Basic & Clinical Medicine, 2022, 42(6): 979-982.

参考文献

[1] Saklayen MG. The global epidemic of the metabolic syndrome[J]. Curr Hypertens Rep, 2018, 20: 12-23.
[2] Katsimardou A, Imprialos K, Stavropoulos K, et al. Hypertension in metabolic syndrome: novel insights[J]. Curr Hypertens Rev, 2020, 16: 12-18.
[3] Nehus E, Mitsnefes M. Childhood obesity and the metabolic syndrome[J]. Pediatr Clin North Am, 2019, 66: 31-43.
[4] Jin M, Zhang Z, Li Y, et al. U-shaped associations between urinary iodine concentration and the prevalence of metabolic disorders: a Cross-Sectional Study[J]. Thyroid, 2020, 30: 1053-1065.
[5] Baldini E, Virili C, D'armiento E, et al. Iodine status in schoolchildren and pregnant women of Lazio, a central region of Italy[J]. Nutrients, 2019, 11:1647-1653.
[6] O'kane SM, Mulhern MS, Pourshahidi LK, et al. Micronutrients, iodine status and concentrations of thyroid hormones: a systematic review[J]. Nutr Rev, 2018, 76: 418-431.
[7] Giannocco G, Kizys MML, Maciel RM, et al. Thyroid hormone, gene expression, and central nervous system: where we are[J]. Semin Cell Dev Biol, 2021, 114: 47-56.
[8] Farebrother J, Zimmermann MB, Andersson M. Excess iodine intake: sources, assessment, and effects on thyroid function[J]. Ann N Y Acad Sci, 2019, 1446: 44-65.
[9] Rees L. Iodine excess in children with kidney disease: are we missing hypothyroidism?[J]. Pediatr Nephrol, 2019, 34: 1151-1153.
[10] Teixeira P, Dos Santos PB, Pazos-Moura CC. The role of thyroid hormone in metabolism and metabolic syndrome[J]. Ther Adv Endocrinol Metab, 2020, 11: 10.1177/2042018820917869.
[11] 袁媛, 赵建国, 李彬, 等. 甲状腺功能亢进患者甲状腺激素水平与脂糖代谢及血尿酸的相关性研究[J].国际检验医学杂志, 2019, 40: 169-172.
[12] Ritter MJ, Amano I, Hollenberg AN. Thyroid hormone signaling and the liver[J]. Hepatology, 2020, 72: 742-752.
[13] Jamal MT, Li QL, Li QY, et al. Association of thyroid hormones with blood pressure and arterial stiffness in the general population: The Dali study[J]. J Clin Hypertens (Greenwich), 2021, 23: 363-372.
[14] Guo S, Wang G, Yang Z. Ligustilide alleviates the insulin resistance, lipid accumulation, and pathological injury with elevated phosphorylated AMPK level in rats with diabetes mellitus[J]. J Recept Signal Transduct Res, 2021, 41: 85-92.
[15] Yaribeygi H, Farrokhi FR, Butler AE, et al. Insulin resistance: review of the underlying molecular mechanisms[J]. J Cell Physiol, 2019, 234: 8152-8161.
[16] 李菊, 陈晋, 王珏, 等. 碘过量对小鼠胰岛β细胞形态的影响[J].现代预防医学, 2020, 47: 690-693+726.
[17] 李菊, 李冬, 洪守祥, 等. 学龄前儿童碘营养状况与体重指数关系的横断面研究[J].现代预防医学, 2018, 45: 4447-4451+4455.
[18] Albert L, Carles Z, Adoración G, et al. Iodine deficiency is higher in morbid obesity in comparison with late after bariatric surgery and non-obese women[J]. Obes Surg, 2015, 25:85-89.
[19] Sekizkardes H, Chung ST, Chacko S, et al. Free fatty acid processing diverges in human pathologic insulin resistance conditions[J]. J Clin Invest, 2020, 130: 3592-3602.
[20] Lee KW, Shin D, Song WO. Low urinary Iodine concentrations associated with dyslipidemia in US adults[J]. Nutrients, 2016, 8: 171-182.
[21] 刘焱,李景梅,李秀维,等.高水磺摄入与血脂异常流行病学关联的探索性研究[J].中华流行病学杂志, 2009, 30: 699-701.
[22] Jahandideh F, Wu J. Perspectives on the potential benefits of antihypertensive peptides towards metabolic syndrome[J]. Int J Mol Sci, 2020, 21:2190-2213.
[23] Wang PX, Deng XR, Zhang CH, et al. Gut microbiota and metabolic syndrome[J]. Chin Med J (Engl), 2020, 133: 808-816.
[24] Wang Y, Fu W, Xue Y, et al. Ginsenoside Rc ameliorates endothelial insulin resistance via upregulation of angio-tensin-converting enzyme 2[J]. Front Pharmacol, 2021, 12: 10.3389/fphar.2021.620524.

碘与代谢综合征相关性的研究进展

Research progress on the correlation between iodine and metabolic syndrome

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	齐梦亚, 李玉秀, 余洁, 张化冰, 许翎岭, 李伟, 平凡. 新确诊糖尿病患者增加运动与降低胰岛素抵抗和心血管危险因素相关[J]. 基础医学与临床, 2024, 44(7): 984-988.
[2]	李庆菊, 于然, 陈佳佳, 陈皓瑜, 宋坚, 王万鹏. 雷帕霉素减轻碘佛醇诱导的模型大鼠急性肾损伤[J]. 基础医学与临床, 2024, 44(1): 31-36.
[3]	章远谋, 韩康, 夏瑞, 孙文健, 任晓莹, 王砚. 亚临床甲状腺功能减退症对多囊卵巢综合征患者内分泌代谢特征的影响[J]. 基础医学与临床, 2023, 43(4): 641-646.
[4]	吴巧玲, 田均平, 张大明, 金征宇, 陆晓梅, 于胜会, 王沄. 辐射剂量对第二代双层探测器光谱CT碘定量和单能量图像CT值准确性的影响[J]. 基础医学与临床, 2023, 43(12): 1866-1870.
[5]	赵茂宇, 李佑美, 刘焕云, 毛琦. 胰岛素抵抗标志物在动脉粥样硬化发病中的研究进展[J]. 基础医学与临床, 2022, 42(8): 1302-1305.
[6]	郑天圣, 佟雪巍, 张伊桐, 朱敏, 詹晓蓉. 2型糖尿病心血管并发症发病机制的研究进展[J]. 基础医学与临床, 2022, 42(5): 814-817.
[7]	张蓝月, 张学东. 分泌蛋白Metrnl在不同疾病中作用的研究进展[J]. 基础医学与临床, 2022, 42(11): 1767-1770.
[8]	孙影, 董世云. 妊娠期代谢综合征对母亲健康及后代生长发育影响的研究进展[J]. 基础医学与临床, 2021, 41(10): 1518-1522.
[9]	王雪莹, 郭薇, 谢聪聪, 姚冠峰, 郭晓丽, 和伟, 刘效群. 卵泡液促甲状腺激素水平对辅助生殖技术实验室指标的影响[J]. 基础医学与临床, 2020, 40(10): 1353-1357.
[10]	杨波熊婉媛铁宝霞蔡小玲哈小琴. 糖尿病与细胞焦亡[J]. 基础医学与临床, 2019, 39(7): 1061-1065.
[11]	朱伟郑世霞柯琳秋汪毅陈琼科夏道涵王红漫. SFRP5基因对小鼠肝癌细胞Hepa1-6糖代谢的影响[J]. 基础医学与临床, 2018, 38(9): 1268-1273.
[12]	邱维张薇陶建瓴王海云郑法雷李雪梅. 倍半萜内酯减轻糖尿病小鼠胰岛素抵抗及早期肾损伤[J]. 基础医学与临床, 2018, 38(9): 1292-1297.
[13]	王丽萍宋斌戴燕陈晖张真稳闫彩凤潘云龙. 多种脂源性细胞因子与2型糖尿病患者胰岛素抵抗相关[J]. 基础医学与临床, 2017, 37(9): 1247-1250.
[14]	由继君赵丹玉. 槲皮素促进软脂酸诱导EA.hy926细胞合成IRS2[J]. 基础医学与临床, 2017, 37(2): 249-250.
[15]	王晓晶聂敏孙梅励. MicroRNAs与葡萄糖稳态研究进展[J]. 基础医学与临床, 2014, 34(9): 1272-1276.